D2-type dopamine receptors in postmortem human brain sections from normal and schizophrenic subjects

NeuroReport

Volumn 7, Issue 12, 1996, Pages 1945-1948

  Lahti, Robert A ^a   Roberts, Rosalinda C ^a   Conley, Robert R ^a   Cochrane, Erika V ^a   Mutin, Alex ^a   Tamminga, Carol A ^a  

^a MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

D2; D3; D4; dopamine; human; postmortem; receptor; schizophrenia; 3H racl opride; 3H YM 09151 2

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; RECEPTOR SUBTYPE; RACLOPRIDE; SALICYLAMIDE DERIVATIVE;

ADULT; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR BINDING; SCHIZOPHRENIA; BINDING COMPETITION; BRAIN; DRUG EFFECT; METABOLISM; MIDDLE AGED;

ADULT; BINDING, COMPETITIVE; BRAIN; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; RACLOPRIDE; RECEPTORS, DOPAMINE D2; SALICYLAMIDES; SCHIZOPHRENIA;

EID: 0029658699     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199608120-00016     Document Type: Article

References (16)

1. Civelli O, Bunzow JR, Grandy DK et al. Eur J Pharmacol 207, 277-286 (1991).
2. Meador-Woodruff JH, Damask SP, Wang J et al. Neuropsychopharmacology 15, 17-29 (1966).
3. Matsumoto M, Hidaka K, Tada S et al. Mol Brain Res 29, 157-162 (1996).
4. Lahti RA, Roberts RC and Tamminga CA. NeuroReport 6, 2505-2512 (1995).
5. Van Tol HHM, Bunzow JR, Guan H-C et al. Nature 350, 610-614 (1991).
6. Lahti RA, Evans DL, Stratman NC et al. Eur J Pharmacol 236, 483-486 (1993).
7. Casey DE. Biol Psychiatry 29, 144a (1991)
8. Seeman P. Guan H-C and VanTol HHM. Nature 365, 441-445 (1993).
9. Murray A, Hyde TM, Knable MB et al. J Neurosci 15, 2186-2191 (1995).
10. Sumiyoshi T, Stockmeier CA, Overholser JC et al. Brain Res 681, 109-116(1994).
11. Reynolds GP and Mason SL. J Neurochem 63, 1576-1577 (1994).
12. Reynolds GP and Mason SL. Eur J Pharmacol 281, R5-R6 (1995).
13. Unis AS, Vincent JG and Dillon B. Life Sci 47, 151-155 (1990).
14. Köhler C, Ericson H and Radesäter A-C (1991). Neurosci Lett 126, 107-109 (1991).
15. Lahti RA, Figur LM, Piercey MF et al. Mol Pharmacol 42, 432-438 (1992).
16. Lahti RA, Evans DL, Stratman NC et al. Eur J Pharmacol 236, 483-486 (1991).